Navigation Links
La nuova tecnologia Elekta per la radioterapia oncologica ridefinirà il futuro della lotta contro i tumori
Date:2/4/2013

ATLANTA e STOCCOLMA, 4 febbraio 2013 /PRNewswire/ -- Ad un evento esclusivo che si terrà il 1o marzo 2013, Elekta mostrerà gli incredibili risultati ottenuti nel campo della radioterapia oncologica e nella cura dei pazienti affetti da tumore.

Fondata nel 1972, Elekta è stata la prima azienda a introdurre sul mercato un acceleratore lineare interamente digitale e a realizzare l'integrazione completa della tecnologia di imaging nel sistema di trattamento clinico. Elekta è leader di mercato nello sviluppo di soluzioni per la radioterapia e le neuroscienze, e vanta un eccellente portafoglio di acceleratori lineari, di sistemi dedicati di radiochirurgia e brachiterapia, e di soluzioni software per l'informazione oncologica e per i piani di trattamento clinici.

" Noi di Elekta abbiamo una passione comune, che ci spinge a una ricerca costante e allo sviluppo di nuove soluzioni per il trattamento del tumore che apportino beneficio ai pazienti, agli operatori e ai sistemi sanitari," afferma Tomas Puusepp , CEO e Presidente di Elekta. "Questa incessante dedizione ai pazienti e ai loro operatori sanitari ci ha fornito la giusta motivazione, spingendoci a creare una soluzione tecnologica davvero unica nel campo della radioterapia oncologica."

L'evento di inaugurazione mondiale si terrà venerdì 1o marzo presso il Renaissance Atlanta Waverly Hotel, Atlanta, Georgia, USA, dalle ore 11:00 alle ore 12:00 EST. Per partecipare all'evento o assistere allo streaming in diretta, registrarsi al sito www.elekta.com/revealed.

*La disponibilità del prodotto è soggetta all'autorizzazione locale. Per maggiori informazioni, si prega di contattare:Johan Andersson Melbi, Direttore, Relazioni con gli Investitori, Elekta ABTel: +46-702-100-451, email:

SOURCE Elekta
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Nova Tecnologia da ELEKTA para Radioterapia dará forma ao futuro do tratamento do câncer
2. Elekta to Showcase Broad Portfolio of Cancer Management Solutions at 2013 Arab Health Congress and Exhibition
3. Quebec Clinic Launches Canadian Use of Elektas Agility Beam-Shaping Innovation for Radiation Therapy of Cancer
4. Elekta Raises $52,200 to Support Individuals with Cancer
5. Elekta Introduces MOSAIQ Connectivity for its microSelectron Digital Brachytherapy Afterloader at ASTRO Annual Meeting
6. Elekta and Philips Establish Research Consortium to Leverage a Breakthrough in Cancer Care with Integration of a Linear Accelerator and MR Imaging
7. Elekta Launches New Version of Monaco Treatment Planning System with Segment Shape Optimization
8. ASRT Foundation and Elekta Award More Than $20,000 in Scholarships to Radiation Therapy Students
9. Elekta Technology at Work in 100 Percent of Americas Top Cancer Hospitals
10. Elekta to Showcase Revolutionary Agility Beam-shaping Innovation at Radiation Physics Annual Meeting
11. Elektas Gamma Knife and Radiation Therapy Systems for Cancer Treatment Take Top Three Places in 2012s Best in KLAS for Radiation Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... BOSTON , January 23, 2015 ... development company, is delighted to announce that the Malcolm ... Miles Congreve (Vice President of Chemistry), Fiona ... Weir (Chief Executive Officer and co-founder) for the seminal ...
(Date:1/22/2015)...  ResMed Inc. (NYSE: RMD ) today announced results ... quarter was $423.0 million, a 10 percent increase compared to ... on a constant currency basis). Net income was $91.2 million, ... December 31, 2013. Diluted earnings per share for the quarter ...
(Date:1/22/2015)... 22, 2015 Increasing sophistication among enterprise buyers of ... purchasing in 2015, says Moravia CMO, ... study by market research firm Common Sense Advisory, 15 ... their translation and localization needs. "From a language industry ...
Breaking Medicine Technology:Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 11Moravia Sees Single-Sourcing as Key Localization Trend in 2015 2
... DIEGO , March 16 ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX ) today reported financial results for the fourth quarter and year ended December 31, 2009 . ... , ... ... ...
... Sigma-Aldrich® (Nasdaq: SIAL ) today announced ... Inc., a Berks County, PA. -based provider of ... Animals ( www.aceanimals.com ), a commercial rodent breeder established ... services, and will operate as part of Sigma Advanced ...
Cached Medicine Technology:ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2009 Financial Results 2ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2009 Financial Results 3ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2009 Financial Results 4ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2009 Financial Results 5ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2009 Financial Results 6ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2009 Financial Results 7ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2009 Financial Results 8ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2009 Financial Results 9ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2009 Financial Results 10ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2009 Financial Results 11Sigma-Aldrich Further Expands In Vivo Biology Offering by Signing an Agreement to Acquire Ace Animals, Inc. 2Sigma-Aldrich Further Expands In Vivo Biology Offering by Signing an Agreement to Acquire Ace Animals, Inc. 3Sigma-Aldrich Further Expands In Vivo Biology Offering by Signing an Agreement to Acquire Ace Animals, Inc. 4Sigma-Aldrich Further Expands In Vivo Biology Offering by Signing an Agreement to Acquire Ace Animals, Inc. 5Sigma-Aldrich Further Expands In Vivo Biology Offering by Signing an Agreement to Acquire Ace Animals, Inc. 6Sigma-Aldrich Further Expands In Vivo Biology Offering by Signing an Agreement to Acquire Ace Animals, Inc. 7
(Date:1/22/2015)... January 22, 2015 The Incredible Bulk is ... Pakulski to increase lean muscle by up to 30lbs in ... the attention of HealthyandFitZone.com’s Stan Stevenson, prompting an investigative review. ... is a step-by-step, scientific diet formula that allows the body ...
(Date:1/22/2015)... 2015 Juvent Sports ( http://www.juventsports.com ) ... PGA Merchandise Show to bestow a Juvent Sports Achievement ... golfer, Arlene McKitrick. The award commemorated and congratulated McKitrick ... win. She won her first amateur tournament in 1979 ...
(Date:1/22/2015)... 22, 2015 Carinsurancesavings.biz has released a new ... and dismemberment insurance . , Purchasing an accidental death ... very advantageous. This type of rider provides benefits if the ... be considered a lesser form of life insurance. , ...
(Date:1/22/2015)... IsoComforter, Inc. has introduced the most innovative ... design to treat specific body parts and muscle groups. , ... easy to use patented cold therapy machine with the innovative ... and muscle injuries. IsoComforter has become the industry leader ...
(Date:1/22/2015)... a famous dress online store for wedding dresses and other ... of wedding dresses , and launches a site-wide women’s dress ... on your big day; the wedding gown is the most ... find the most suitable wedding dress. Now, we are proud ...
Breaking Medicine News(10 mins):Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2
... RICHMOND, Va., July 7 "It,s time for Plaintiffs, ... healthcare crisis, and we are making that happen," says ... , SubroShare is a startup healthcare IT company ... common activity known as a request for a patient,s ...
... July 7 Pharmasset, Inc. (Nasdaq: VRUS ... a lead development candidate from two series of purine ... (HCV) infection. PSI-938 is a proprietary nucleotide analog polymerase ... required for submission of an Investigational New Drug (IND) ...
... ... balance, health, and fitness, to attract and retain good talent. However, Freightquote took this ... health, but encourages mental health, financial wellbeing, and education. , ... Lenexa, KS (PRWEB) July 7, 2009 -- ...
... is one of the most vital and dynamic sectors of ... which needs to keep pace with the evolving demands of ... , , New analysis from Frost & Sullivan ( ... Company Profiles , finds that the global medical device market ...
... system offers safe, simple, effective alternative to tubal ligation ... Inc., (Hologic or the Company) (Nasdaq: HOLX ... diagnostics, medical imaging systems and surgical products dedicated to ... U.S. Food and Drug Administration (FDA) has approved the ...
... Americans aren,t willing to give up aesthetic injections and ... in today,s job market or simply to maintain a youthful ... time of a recent Kelton Research* survey more than 40 ... injections within the next six months.(1) , , Despite ...
Cached Medicine News:Health News:New Software Makes Lawyers Accountable for Their Part in Our Healthcare Crisis 2Health News:Pharmasset Nominates PSI-938 as a New Nucleotide Analog Inhibitor of Hepatitis C for Preclinical Development 2Health News:Pharmasset Nominates PSI-938 as a New Nucleotide Analog Inhibitor of Hepatitis C for Preclinical Development 3Health News:Freightquote.com Encourages Healthy Lifestyle, FreightFit Changes Lives 2Health News:Freightquote.com Encourages Healthy Lifestyle, FreightFit Changes Lives 3Health News:Frost & Sullivan Identifies Innovative and Cost-Effective Technology as Key Competitive Factor in European Medical Device Market 2Health News:Frost & Sullivan Identifies Innovative and Cost-Effective Technology as Key Competitive Factor in European Medical Device Market 3Health News:Video: FDA Approves Hologic's Adiana(R) Permanent Contraception System 2Health News:Video: FDA Approves Hologic's Adiana(R) Permanent Contraception System 3Health News:Video: FDA Approves Hologic's Adiana(R) Permanent Contraception System 4Health News:Video: FDA Approves Hologic's Adiana(R) Permanent Contraception System 5Health News:New Survey Reveals High Expectations for Popular Aesthetic Injections 2Health News:New Survey Reveals High Expectations for Popular Aesthetic Injections 3
Streck-CD3500 Hemoglobin/Lyse is a lytic reagent for the quantitative determination of hemoglobin on the Abbott CELL-DYN® 3500 and 3700. The shelf life is two years from the date of manufacture....
Streck-Diluent IIIA is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 1700. The shelf life is one year f...
... establish the patient reportable range and establish ... Linearity is available in five-vial sets with ... 3700 and 4000; Bayer ADVIA 120; Coulter ... 755; Sysmex R-3000, R-3500, R-1000, RAM-1, XE-2100 ...
... nRBC-Chex for LH is a nucleated red blood ... precision of the Coulter LH 750/LH 755 hematology ... The assay provides for the Coulter LH 750/LH ... packaged in plastic, cap-pierceable vials. nRBC-Chex for LH ...
Medicine Products: